Marked benefit with sustained-release niacin therapy in patients with "isolated" very low levels of high-density lipoprotein cholesterol and coronary artery disease.
Lavie
C J
CJ
Department of Internal Medicine, Ochsner Medical Institutions, New Orleans, Louisiana.
Mailander
L
L
Milani
R V
RV
D008076:Cholesterol, HDL / Q000097:blood*; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D006801:Humans; D015228:Hypertriglyceridemia / Q000188:drug therapy; D008297:Male; D009525:Niacin / Q000627:therapeutic use*
D008076:Cholesterol, HDL; D003692:Delayed-Action Preparations; D009525:Niacin